Liquidia Corp (LQDA) Reports Full Year 2023 Financial Results
Key Financial Highlights and Corporate Updates
Stay updated with breaking news from Liquidia Corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Key Financial Highlights and Corporate Updates
(Reuters) - United Therapeutics said on Wednesday it has commenced litigation with the U.S. FDA for allowing an application for a drug by Liquidia Corp to treat a type of blood vessel disorder. (Reporting by Leroy Leo in Bengaluru; Editing by Shin...
United Therapeutics said on Wednesday it has filed a case with the U.S. FDA, alleging that due procedure was not followed in allowing rival Liquidia Corp's…
Liquidia Corp. moved closer to gaining final regulatory approval for its Yutrepia drug as a US appeals court rejected United Therapeutics Corp.'s attempt to revive a patent for Tyvaso that an administrative tribunal canceled.
Liquidia Corp (NASDAQ: LQDA) stock jumped after a win in a pat